Singapore-based synthetic biology startup Allozymes has raised $5 million in seed funding led by Xora Innovation, the deep science investment arm of Temasek Holdings. The round was also joined by SOSV, TI Platform Management and Entrepreneur First.
Allozymes was founded in 2019 by Peyman Salehian and Akbar Vahidi, two PhD scientists from the National University of Singapore. It focuses on enzyme engineering, which Allozymes believes will play an increasingly crucial role in the bio-manufacturing of industrial ingredients across food, pharma, cosmetics and fuel sectors.
